Lindy Biosciences is focused on enhancing patient comfort and autonomy in drug delivery, particularly for those with chronic illnesses. The company is developing patient-centric biotherapeutic drug delivery technologies that allow for self-administration of medications at home, moving away from the traditional intravenous infusions typically used in acute care settings. Their innovative approach aims to improve the overall experience for patients by providing more convenient and accessible treatment options.

Central to Lindy Biosciences' offerings is their proprietary Microglassification™ technology, which facilitates the formulation of biotherapeutics for easier self-administration. This technology is designed to empower patients by returning control over their medication delivery, thereby improving their quality of life. Lindy is actively seeking collaborations with industry partners to leverage this platform in the development of new drug delivery products, emphasizing their commitment to innovation and patient-centered care in the biotherapeutics space.

United States

Lindy Biosciences is a development-stage protein therapeutic formulations company. Their core technology, Microglassification™, produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for incorporation into drug delivery formulations such as suspensions(for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.​

Lindy Biosciences

Company Details